Pro 2014-020 (Framework Agreement on Jianfeng Group's Acquisition of Nestor)
Release time:
2020-08-05
Securities Code: 600668 Securities Short Name: Jianfeng Group Announcement No.: 2014-020
Bond Short Name: 13 Jianfeng 01 Bond Code: 122227
Zhejiang Jianfeng Group Co., Ltd.
Reminder Announcement on the Signing of Equity Transfer Framework Agreement by Subsidiaries
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important Content Reminder:
l Transaction Brief Content: Zhejiang Jianfeng Pharmaceutical Co., Ltd., the company's holding subsidiary, recently signed the "Framework Agreement on Equity Transfer of Zhejiang Neshikang Pharmaceutical Co., Ltd." with Creative Medicine and Xi 'an Zizhitong Investment Co., Ltd. to transfer 70% and 25% of the equity of Zhejiang Neshikang Pharmaceutical Co., Ltd.
l This transaction does not constitute a related party transaction
l This transaction does not constitute a major asset reorganization
l There are no major legal obstacles to the implementation of the transaction
l This is a framework agreement, which is the preliminary result of the preliminary negotiations, and the follow-up work has been arranged. The specific matters of equity acquisition need to be further negotiated according to the results of audit, evaluation and due diligence. The formal equity transfer agreement will also be submitted to the company's board of directors or general meeting of shareholders for approval in accordance with the "Stock Listing Rules", the company's articles of association, etc., before it can take effect. There is uncertainty as to whether the equity acquisition will be realized.
Overview of 1. Transaction
Basic Information of (I) Transaction
Zhejiang Jianfeng Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianfeng Pharmaceutical"), the controlling subsidiary of the Company, plans to acquire 70% equity of Zhejiang Neisikang Pharmaceutical Co., Ltd. (hereinafter referred to as "Neisikang Pharmaceutical") held by Creative Medicine (hereinafter referred to as "CM Company") and Xi 'an Zizhitong Investment Co., Ltd. The company (hereinafter referred to as "Zizhitong Company") holds a 25% stake in Nesikang Pharmaceuticals, the total of the two is 95% equity.
(II) company approval.
This is a framework agreement. The specific matters of the equity acquisition need to be further negotiated and negotiated based on due diligence, audit or evaluation results, and will be in accordance with the provisions of the Stock Listing Rules, the company's articles of association, etc. It can be implemented after being submitted to the company's board of directors or shareholders meeting for approval. There is the possibility of changes in the implementation and implementation process of the framework agreement.
This equity transfer does not involve connected transactions, nor does it constitute a major asset reorganization as stipulated in the Measures for the Administration of Major Asset Reorganization of Listed Companies.
Basic Information of 2. Counterparty
(I) Creative Medicine
, Enterprise Name: Creative Medicine
2, Enterprise Nature: Limited Liability Company
3, Place of Registration: Cayman
, Main Office Location: 190 Elgin Street, Grand Cayman, Cayman Islands, ( KY1-9005)
, Legal Representative: Yang Zhi
, Paid-in Capital: US $13.5 million
7, Main Business: Investment and Investment Management
, Major Shareholder or Actual Controller: bioVeda China Fund II L.P.;New Enterprise Associates 13,Limited Partnership;Yifang Technology Group, Ltd.
9, 2013 main financial indicators: total assets of $41.0119 million, net assets of $13.3334 million, net profit of-$2800.
(II) Xi' an zizhitong investment co., ltd.
1, enterprise name: Xi' an zizhitong investment co., ltd.
2, enterprise nature: limited liability company (natural person investment or holding)
3, place of registration:
4 on the east side of the 10th floor of Zhongsheng Building, 69 Jinye Road, Xi 'an High-tech Zone, main office location:
5 on the east side of the 10th floor of Zhongsheng Building, 69 Jinye Road, Xi 'an High-tech Zone, legal representative: Zhang Hua
6, registered capital: 100 million yuan
7, main business: industrial investment and venture investment; asset management (excluding financial services), investment management and consulting.
8, major shareholder or actual controller: Zhang Hua
9, main financial indicators for 2013 (RMB): total assets of 257.0996 million yuan, net assets of 104.9223 million yuan, net profit of -5.3861 million yuan.
Basic Information of 3. Transaction Target
1, Target Name: 95 Equity of Zhejiang Nesikang Pharmaceutical Co., Ltd.;
2, major shareholder: CM Company holds 70% equity; Zizhitong Company holds 25% equity; zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. holds a 5% stake;
3, legal representative: Yang Zhi;
4, main business: drug bulk drug production; The main products are karat , azithromycin , fenofibrate, etc.
5, registered capital: US $36.10667 million;
6, Company Type: Limited Liability Company (Sino-foreign Joint Venture)
7, Establishment Date: December 23, 2002;
8, place of registration: 1318 Jinsha Street, Linjiang Industrial Zone, Wucheng District, Jinhua City;
9, Nesikang Pharmaceutical's 2013 financial report was audited by Jinhua Zhongjian Joint Accounting Firm, with main financial indicators:
Project (RMB 10,000) |
at the end of 2013 |
Total Assets |
43625.72 |
Total Liabilities |
26889.44 |
Net Assets |
16736.28 |
2013 |
|
Operating Income |
28776.51 |
Net Profit |
435.01 |
The company will entrust an audit institution with securities and futures business qualifications to carry out necessary audit on the financial statements of Neisikang Pharmaceutical, the audit results may differ from the above financial data. Main Contents of
4. Framework Agreement
"Party A": Zhejiang Jianfeng Pharmaceutical Co., Ltd.
"Party B": creative Medicine and Xi' an zizhitong investment co., ltd.
(I) equity transfer, price payment
1.CM company jointly transferred its 70% equity of nesikang pharmaceutical and zizhitong company its 25% equity of nesikang pharmaceutical to party a.
2, A and B agree on the transfer price after considering the audit, evaluation report, market trend and other comprehensive factors that may affect the operation efficiency.
3. The transfer price will be priced in RMB and paid to Party B in installments.
(II) Assets Evaluation
Within 15 working days after the signing of the framework agreement, intermediary agencies with securities qualification such as audit and evaluation hired by Party A and approved by Party B shall conduct a comprehensive audit, evaluation and due diligence on Neisikang Pharmaceutical, and strive to complete the audit, evaluation and due diligence within no more than 30 working days. Naisikang Pharmaceuticals and Party B shall provide the greatest convenience for the audit, evaluation and due diligence work, provide relevant information in a timely manner, and undertake to provide complete and true information required for the audit, evaluation and due diligence work. Otherwise, it will bear the corresponding legal responsibility.
(III) exclusive matters
Unless approved in writing by Party A, within 60 working days after this agreement comes into effect (hereinafter referred to as exclusive period), party B and any representative under its control shall not, directly or indirectly, seek to contact, negotiate, negotiate or sign any agreement or letter of intent with any third party (whether or not such agreement or letter of intent is binding on it) with respect to any matter agreed upon in this Agreement. During the exclusive period, Party B shall ensure the achievement of the transfer conditions, and the Buyer shall draft the equity transfer agreement and other transaction documents for negotiation. The term of this agreement and the exclusive period may be extended with the consent of the parties.
5. the impact and risk tips of this transaction
This equity acquisition is the specific implementation of the company's strategic plan and 2014 business plan. If the equity transfer can be successfully completed, it will expand the scope and scale of the company's pharmaceutical business.
In view of the fact that this framework agreement only determines the basic framework of the transaction, it is still necessary to further reach an equity transfer agreement on the basis of audit, evaluation and due diligence, and submit it to the company's board of directors or shareholders' meeting for consideration. There is uncertainty about whether the transaction can be realized. The company will be based on the progress of the acquisition of the progress of the timely disclosure of the follow-up progress, so that the majority of investors pay attention to investment risks.
hereby announce
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
July 28, 2014
More information
Create a safe environment to meet the G20
The G20 summit will be held in Hangzhou from September 4 to 5. On August 8, the safety committee of the group company will hold a meeting to make arrangements and put forward requirements for the key work of safety and environmental protection from now to the summit. At the meeting, Chen Tianci, director of the safety management office of the group company, conveyed the requirements of the provincial, municipal and district governments during the G20 summit. Combined with the specific situation and work characteristics of each enterprise, he put forward requirements for environmental protection, safety, public security and other work. In terms of environmental protection management, we must strictly implement the company's environmental protection system, focusing on the management and disposal of solid waste, and the emission control of sewage and dust; at present, in the high temperature season, we must focus on strengthening fire safety management, especially warehousing and hazardous chemical business units., We must strictly do a good job in daily safety inspections; all enterprises must promptly convey the relevant spirit of their superiors to each employee, strengthen ideological and political work, and create a good and harmonious corporate atmosphere. Xiang Chongping, deputy general manager of the group company, supplemented the territorial management of related matters of various enterprises, properly handling internal contradictions, and strengthening network security management. Yu Jianhong, general manager of the group company, stressed at the meeting that safety and environmental protection work should be talked about and grasped every day, and should not be relaxed at any time. Safety accidents seem to be accidental, but in fact they are inevitable, and their roots lie in the usual violations and carelessness. Therefore, all enterprises should seriously organize their employees to carry out self-examination and self-correction, effectively improve their safety awareness, and find out and rectify the small problems and hidden dangers that have been ignored in their work in the past. At the same time, it is necessary to do a good job in the safety zone of operation and the protection of related facilities, through advanced control systems, safe facilities and equipment, standardized
2020
07-31
Create a safe environment to meet the G20
The G20 summit will be held in Hangzhou from September 4 to 5. On August 8, the safety committee of the group company will hold a meeting to make arrangements and put forward requirements for the key work of safety and environmental protection from now to the summit. At the meeting, Chen Tianci, director of the safety management office of the group company, conveyed the requirements of the provincial, municipal and district governments during the G20 summit. Combined with the specific situation and work characteristics of each enterprise, he put forward requirements for environmental protection, safety, public security and other work. In terms of environmental protection management, we must strictly implement the company's environmental protection system, focusing on the management and disposal of solid waste, and the emission control of sewage and dust; at present, in the high temperature season, we must focus on strengthening fire safety management, especially warehousing and hazardous chemical business units., We must strictly do a good job in daily safety inspections; all enterprises must promptly convey the relevant spirit of their superiors to each employee, strengthen ideological and political work, and create a good and harmonious corporate atmosphere. Xiang Chongping, deputy general manager of the group company, supplemented the territorial management of related matters of various enterprises, properly handling internal contradictions, and strengthening network security management. Yu Jianhong, general manager of the group company, stressed at the meeting that safety and environmental protection work should be talked about and grasped every day, and should not be relaxed at any time. Safety accidents seem to be accidental, but in fact they are inevitable, and their roots lie in the usual violations and carelessness. Therefore, all enterprises should seriously organize their employees to carry out self-examination and self-correction, effectively improve their safety awareness, and find out and rectify the small problems and hidden dangers that have been ignored in their work in the past. At the same time, it is necessary to do a good job in the safety zone of operation and the protection of related facilities, through advanced control systems, safe facilities and equipment, standardized
2020
07-30
Technological Innovation Brings Enterprises to the International Stage
Editor's note: As a 17-year-old senior enterprise in the extract industry, Tianjin Jianfeng Natural Products Research and Development Company has devoted more time, energy and funds to R & D and innovation while doing a good job in business operations. It has always been an important direction for them to achieve self breakthrough by turning waste into treasure and technological innovation. Therefore, it has achieved the improvement of market popularity at home and abroad and the rapid growth of sales volume, and has become a key science and technology enterprise in Tianjin Binhai New Area. On July 9, the "Bohai Morning Post" "TEDA Technology Little Giant Tour" column published an exclusive interview, describing the growth experience and a series of achievements of Tianjin Jianfeng Natural Products Company. This article will be reproduced in this newspaper for readers. "Little grape seed" grows into a little giant of science and technology to solve the problem of pesticide residues in plant extracts. Technological innovation has enabled the enterprise to step onto the international stage based on independent innovation and development. Starting from the initial grape seed extraction process, it has gradually grown into the largest professional fruit extract manufacturer in China with dozens of plant extract products conforming to international strict standards and an annual productivity of 2000 tons, tianjin Jianfeng Natural Products Research and Development Co., Ltd. (hereinafter referred to as "Tianjin Jianfeng") has gone through a decade of rapid development. As a supplier of raw materials in health food, beverages, cosmetics, baked goods and many other fields, the concept of "truth and safety" advocated by Tianjin Jianfeng has run through all aspects of R & D and production. Its products are not only well-known in China, but also exported to Europe and the United States. Become a new business card of TEDA. Technological innovation is in line with international standards. "In people's lives, the beverages they drink, the health foods they eat, and the cosmetics they use will contain plant extracts.
2020
07-31
Create a safe environment to meet the G20
The G20 summit will be held in Hangzhou from September 4 to 5. On August 8, the safety committee of the group company will hold a meeting to make arrangements and put forward requirements for the key work of safety and environmental protection from now to the summit. At the meeting, Chen Tianci, director of the safety management office of the group company, conveyed the requirements of the provincial, municipal and district governments during the G20 summit. Combined with the specific situation and work characteristics of each enterprise, he put forward requirements for environmental protection, safety, public security and other work. In terms of environmental protection management, we must strictly implement the company's environmental protection system, focusing on the management and disposal of solid waste, and the emission control of sewage and dust; at present, in the high temperature season, we must focus on strengthening fire safety management, especially warehousing and hazardous chemical business units., We must strictly do a good job in daily safety inspections; all enterprises must promptly convey the relevant spirit of their superiors to each employee, strengthen ideological and political work, and create a good and harmonious corporate atmosphere. Xiang Chongping, deputy general manager of the group company, supplemented the territorial management of related matters of various enterprises, properly handling internal contradictions, and strengthening network security management. Yu Jianhong, general manager of the group company, stressed at the meeting that safety and environmental protection work should be talked about and grasped every day, and should not be relaxed at any time. Safety accidents seem to be accidental, but in fact they are inevitable, and their roots lie in the usual violations and carelessness. Therefore, all enterprises should seriously organize their employees to carry out self-examination and self-correction, effectively improve their safety awareness, and find out and rectify the small problems and hidden dangers that have been ignored in their work in the past. At the same time, it is necessary to do a good job in the safety zone of operation and the protection of related facilities, through advanced control systems, safe facilities and equipment, standardized
2020
07-31
The company requires each business segment to formulate medium-and long-term business plans.
According to our newspaper, "if an enterprise wants to develop in the long run, first of all, managers should have a long-term vision." On July 24, when general manager Yu Jianhong deployed the work for the second half of the year at the semi-annual meeting of the group company, he specifically asked all enterprises to formulate specific medium-and long-term business development plans for the next three to five years according to the industrial development trend and the group development strategy. Before making arrangements for the specific key work in the second half of the year, Yu Jianhong emphatically put forward the requirements for each business sector to formulate a business strategy plan for 2016-2018 according to the industry development trend and the group's development strategy. Yu Jianhong pointed out that the current group company's strategic decision-making and strategic development capabilities and efficiency still need to be improved. The publicity, understanding and implementation of the group's development strategy by various companies are not in place. The lack of medium and long-term business planning in each business sector restricts the business of the company. Development, cultivation of core products and profitability, construction of product brands, improvement of business scale and comprehensive strength. Last year, the group company asked the international trading company to formulate three-year work objectives and sign a three-year economic responsibility system with the company's management team. The actual effect shows that this has made the management team's management ideas clearer and more scientific and rational in terms of target setting, work arrangement and business development. For this reason, the group company put forward the requirements for the formulation of medium and long-term development plans for each business sector at this meeting. According to the industry characteristics of each business segment, market environment and other specific circumstances, the company makes requirements for the key content of the development plan of each business segment. For example, the pharmaceutical sector focuses on sales growth targets for key profitable products, product development and
2020
07-31
The company requires each business segment to formulate medium-and long-term business plans.
According to our newspaper, "if an enterprise wants to develop in the long run, first of all, managers should have a long-term vision." On July 24, when general manager Yu Jianhong deployed the work for the second half of the year at the semi-annual meeting of the group company, he specifically asked all enterprises to formulate specific medium-and long-term business development plans for the next three to five years according to the industrial development trend and the group development strategy. Before making arrangements for the specific key work in the second half of the year, Yu Jianhong emphatically put forward the requirements for each business sector to formulate a business strategy plan for 2016-2018 according to the industry development trend and the group's development strategy. Yu Jianhong pointed out that the current group company's strategic decision-making and strategic development capabilities and efficiency still need to be improved. The publicity, understanding and implementation of the group's development strategy by various companies are not in place. The lack of medium and long-term business planning in each business sector restricts the business of the company. Development, cultivation of core products and profitability, construction of product brands, improvement of business scale and comprehensive strength. Last year, the group company asked the international trading company to formulate three-year work objectives and sign a three-year economic responsibility system with the company's management team. The actual effect shows that this has made the management team's management ideas clearer and more scientific and rational in terms of target setting, work arrangement and business development. For this reason, the group company put forward the requirements for the formulation of medium and long-term development plans for each business sector at this meeting. According to the industry characteristics of each business segment, market environment and other specific circumstances, the company makes requirements for the key content of the development plan of each business segment. For example, the pharmaceutical sector focuses on sales growth targets for key profitable products, product development and
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page